IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Cosentini, Deborah
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.495
AS - Asia 2.821
EU - Europa 2.225
SA - Sud America 448
Continente sconosciuto - Info sul continente non disponibili 176
AF - Africa 60
OC - Oceania 4
Totale 11.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.360
SG - Singapore 1.061
CN - Cina 685
IT - Italia 612
BR - Brasile 356
PL - Polonia 347
FI - Finlandia 260
HK - Hong Kong 258
DE - Germania 242
BD - Bangladesh 235
VN - Vietnam 220
GB - Regno Unito 116
UA - Ucraina 112
FR - Francia 110
TR - Turchia 89
RU - Federazione Russa 86
CA - Canada 82
IE - Irlanda 82
IN - India 76
SE - Svezia 51
ID - Indonesia 41
CZ - Repubblica Ceca 40
AR - Argentina 38
JP - Giappone 37
NL - Olanda 36
ES - Italia 31
MX - Messico 28
BE - Belgio 27
ZA - Sudafrica 23
IQ - Iraq 21
AT - Austria 16
CH - Svizzera 13
PK - Pakistan 13
EC - Ecuador 12
CL - Cile 11
SA - Arabia Saudita 10
LT - Lituania 9
MA - Marocco 9
PT - Portogallo 9
UZ - Uzbekistan 9
DZ - Algeria 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
CR - Costa Rica 7
JM - Giamaica 7
JO - Giordania 6
VE - Venezuela 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
KE - Kenya 5
LB - Libano 5
PY - Paraguay 5
TW - Taiwan 5
EG - Egitto 4
ET - Etiopia 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
AU - Australia 3
GY - Guiana 3
HN - Honduras 3
KG - Kirghizistan 3
LV - Lettonia 3
OM - Oman 3
UY - Uruguay 3
BO - Bolivia 2
EE - Estonia 2
IL - Israele 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
ZW - Zimbabwe 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 11.054
Salva come PNG Salva come JPEG
Città #
Singapore 548
Ashburn 521
Dallas 388
San Jose 361
Warsaw 341
Fairfield 275
Hong Kong 257
Chicago 246
Los Angeles 211
New York 198
Helsinki 191
Beijing 160
Chandler 157
Council Bluffs 130
Seattle 125
The Dalles 118
Houston 116
Woodbridge 111
Salt Lake City 101
Wilmington 98
Munich 92
Jacksonville 80
Cambridge 79
Brescia 77
Buffalo 71
Istanbul 69
Princeton 69
Columbus 67
Milan 62
Ho Chi Minh City 61
Lauterbourg 61
Secaucus 60
Santa Clara 54
Tampa 52
Dublin 48
Shanghai 48
Turku 48
Elk Grove Village 47
Boardman 44
Ann Arbor 43
Moscow 42
Hanoi 40
Redondo Beach 38
Jakarta 37
Rome 37
Dalmine 36
Orem 33
Brno 32
West Jordan 30
Des Moines 28
Dong Ket 28
Sterling 28
Bergamo 27
São Paulo 27
Brussels 26
San Francisco 26
London 25
Naples 25
Montreal 24
Menlo Park 22
Phoenix 22
Lancaster 21
Brooklyn 20
Dearborn 20
Poplar 20
Romola 20
Stockholm 20
Atlanta 19
Nuremberg 18
Rio de Janeiro 18
Tokyo 18
Chennai 17
Frankfurt am Main 17
Johannesburg 17
Lappeenranta 17
Nanjing 17
Mumbai 16
San Diego 16
Toronto 16
Boston 15
Denver 15
Dulles 14
Pune 14
Detroit 13
Haiphong 13
Miami 13
Washington 13
Amsterdam 12
Las Vegas 12
Charlotte 11
Guangzhou 11
Tianjin 11
Biên Hòa 10
New Delhi 10
Paris 10
Ankara 9
Changsha 9
Da Nang 9
Gumyojicho 9
Kansas City 9
Totale 7.087
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 794
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 383
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 258
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 256
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 254
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 252
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Immunotherapy failure in adrenocortical cancer: where next? 224
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 203
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 200
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 194
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 191
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 190
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 185
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 183
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 174
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 167
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 166
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 159
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 155
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 150
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 150
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 141
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 140
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 134
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 133
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 131
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 131
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 130
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 130
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 123
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 121
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 121
Transformation of prostate adenocarcinoma into small-cell neuroendocrine cancer under androgen deprivation therapy: Much is achieved but more information is needed 120
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 119
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 119
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 115
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 115
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 113
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 113
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 111
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 109
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 106
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 104
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 102
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 102
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 102
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 102
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 98
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 95
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 95
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 94
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 91
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 91
Adjuvant denosumab for early breast cancer-Evidence and controversy 90
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 89
The Evolving Treatment Landscape of Medullary Thyroid Cancer 87
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 86
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 85
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 84
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 82
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial 81
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 78
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 78
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 71
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 65
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 63
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 62
Real-world use of multigene signatures in early breast cancer: differences to clinical trials 61
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 58
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 54
Oligometastatic adrenocortical carcinoma: definition and treatment 51
null 51
Case Report: Pathologic complete response in triple negative breast cancer treated with anthracycline free regimen 48
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 43
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 41
The role of 2-[18F]FDG PET/CT in adrenocortical carcinoma: a systematic review 36
Quality of life questionnaire development and validation for adrenocortical carcinoma patients 33
Efficacy of RET inhibitors in the management of advanced, RET mutated, pheochromocytoma. Pooled analysis of published cases with the addition of 2 new cases 32
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 24
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 24
Primary Adrenal Malignancies 16
Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study 14
Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study) 13
Regional adrenalectomy completed by prophylactic hyperthermic intraperitoneal chemotherapy reduces the incidence of local and peritoneal recurrence after curative surgery for adrenocortical carcinoma 8
Updating ACC preclinical models: characterization of two new patient-derived cell lines 8
Totale 11.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022361 0 10 12 76 19 27 15 20 17 55 31 79
2022/2023440 50 22 27 31 36 96 4 48 56 16 29 25
2023/2024918 43 31 74 75 74 171 27 50 129 61 23 160
2024/20252.833 54 45 30 414 174 131 154 88 293 122 675 653
2025/20264.720 343 507 570 484 392 331 562 191 326 441 300 273
2026/2027322 190 132 0 0 0 0 0 0 0 0 0 0
Totale 11.229